Tight binding inhibitors of xanthine oxidase by Hille, Russ & Massey, Vincent
Pharnu..  Ther. Vol. 14, pp. 249 to 263. 1981 11163-7258 81 I)20249-15~17 50 0 
Printed in Great Britain. All rights reserved Copyright  rc ~ 1981 Pergamon Prc~,~ Lid 
Specialist Subject Editor: SUNGMAN CHA 
T I G H T  B I N D I N G  I N H I B I T O R S  O F  X A N T H I N E  O X I D A S E  
Russ HILLE and VINCENT MASSEY 
Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109, U.S.A. 
1. INTRODUCTION 
Xanthine oxidase catalyzes the oxidation of hypoxanthine to xanthine and xanthine to 
uric acid as follows 
OH OH OH 
- OH 
N , o  . ".o 
H H202 H HzO2 H 
Hypoxanthine Xanthine Uric Acid 
The enzyme is well-suited to carry out the catalysis of these oxidative reactions, contain- 
ing as it does four redox-active sites: molybdenum, flavin adenine dinucleotide (FAD) 
and a pair of iron-sulfur centers of the ferredoxin type (Fe2S2). The purine substrates 
interact with the enzyme at the molybdenum site of xanthine oxidase and oxygen at the 
flavin site. The two metabolic reactions above Constitute the final steps of purine catab- 
olism in primates and as such play an important role in determining the in vivo steady 
state levels of the various purines, particularly that of uric acid. The introduction of 
potent inhibitors of xanthine oxidase has proven a clinically effective way to control the 
hyperuricemia associated with gout (Elion et al., 1963; Duggan et al., 1975; cf. Rundles et 
al., 1969, for a review) and attenuate the activity of mercaptopurinol and other antileuke- 
mic drugs (Rundles et al., 19631. In addition, in vitro studies on the mechanism of action 
of these compounds have shed considerable light on the properties of the enzyme itself 
(e.g. Massey et al., 1970a,b). This review will concern itself primarily with such in vitro 
studies, and the reader is referred to the review by Rundles et al., for clinical consider- 
ations. Two review articles onthe general properties of xanthine oxidase have appeared 
recently (Massey, 1973; Bray, 19751. 
Potent inhibitors of xanthine oxidase can be divided into two broad categories: (11 
molecules which are analogs of the purine substrates to a greater or lesser extent and (2) 
molecules which bear no particular structural relationship to the physiological sub- 
strates. The former group consists of pyrazolo[3,4-d]pyrimidines (alloxanthine being the 
most important among them), pterins such as 6-pteridylaldehyde, and certain other 
aromatic heterocycles. Included in the latter group are cyanide, arsenite, and methanol, 
compounds which do not inhibit xanthine oxidase exclusively, but nonetheless interact 
very specifically with the enzyme. Both classes of inhibitors act at or very near the 
molybdenum site of the enzyme, or with the active site cyanolysable sulfur atom (cf. 
Section 3.11, and interfere with the reaction of enzyme with the reducing substrates 
(hydroxypurines) rather than oxygen. The following discussion will deal first with the 
purine analogs, about which a good deal is known, and then take up the second class of 
inhibitors, about which a good deal less is understood. 
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2. P U R I N E  A N A L O G S  
2.1 .  A L L O P U R I N O L  A N D  A L L O X A N T H I N E  
2.1.1. Mechanism ~" Action 
Pyrazolo[3,4-d]pyrimidines were first reported to be inhibitors of xanthine oxidase by 
Feigelson et  al. (1957). Later clinical and enzymological studies by Elion and coworkers 
established that allopurinol (4-hydroxypyrazolo[3,4-d]pyrimidine) was a particularly 
effective inhibitor in vivo as well as in vi tro (Elion et al., 1963, 1966; Rundles et al., 1963). 
It was further shown that allopurinol was enzymatically oxidized to the 4,6-dihydroxy 
compound alioxanthine (Elion et al., 1966). Prior incubation of xanthine oxidase with 
allopurinol resulted in total loss of activity in xanthine-oxygen oxidoreduction assays, 
whereas incubation with alloxanthine resulted in no initial inhibition, but progressive 
inactivation during the course of the assays (Elion, 1966). These findings suggested that 
inactivation was due to inhibitor binding to an intermediate in the catalytic cycle. 
OH OH 
H 2 O, O z LN ~~N/ N 
N ~ "HO 
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A IIopurinol A IIoxonthine 
Subsequent work by Massey and coworkers (Massey et  al., 1970a,b) established that 
allopurinol inhibited xanthine oxidase by forming a very tight complex with reduced 
molybdenum at the active site after having been oxidized by the enzyme to alloxanthine. 
When xanthine oxidase was incubated with allopurinol under anaerobic conditions, 
significant reduction of the enzyme was observed spectrophotometrically (Fig. 1, curve 2). 
On admission of air the enzyme became reoxidized, but the spectrum of the inactive 
material obtained (Fig. 1, curve 3) differed from that of untreated enzyme (curve 1). An 
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FIG. 1. Effect of allopurinol on the spectrum of xanthine oxidase. Curve 1, untreated enzyme, 
2.38 x 1 0 - s M  with respect to FAD, in 0.1M pyrophosphate p H  8.5, 25°C. Curve  2, spectrum 
recorded 5rain after the addition of 1.67 x t0-4~,!  allopurinol anaerobically. The spectrum 
remained unchanged over a period of 2 hr. Curve 3, immediately after mixing with air; further 
addition of allopurinol or xanthine anaerobically resulted in no spectral changes over a period of 
2 hr (From Massey et  al., 1970b). 
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identical spectrum could be obtained if alloxanthine plus xanthine was used in place of 
allopurinol, implicating alloxanthine as the actual inhibiting species. In both cases, the 
difference between the spectra taken before and after admission of air was identical to the 
difference between the spectra of oxidized enzyme and enzyme reduced by xanthine 
(Fig. 2). This strongly suggested that the iron-sulfur and FAD chromophores of the enzyme 
were unaltered and that alloxanthine was interacting at the molybdenum site. Further- 
more, when the inhibited reoxidized enzyme was incubated with potassium ferricyanide, 
an additional two electron equivalents per active site were extracted from the enzyme, 
resulting in full recovery of activity and a return of the spectrum to that of native 
enzyme. As the iron-sulfur and FAD sites were oxidized at the outset, this indicated that 
the molybdenum was still reduced in the inhibitory complex. This inhibitory complex 
between alloxanthine and reduced molybdenum precludes catalytic reaction involving 
the molybdenum site, but has no effect on the NADH-ferricyanide activity of xanthine 
oxidase (Elion, 1966), an activity known to involve only the iron-sulfur and FAD sites of 
the enzyme (Komai et  al., 1969). 
Alloxanthine binding was found to be so tight that even at an enzyme concentration of 
5 × 10-6M it bound to the reduced enzyme stoichiometrically (Massey et  al., 1970a). 
This permitted its use in functional site titrations of protein samples and led to the 
recognition of appreciable amounts (20% or more) of inactive xanthine oxidase in appar- 
ently homogenous enzyme preparations. An affinity chromatography technique for 
resolving active and inactive xanthine oxidase was subsequently developed that relied on 
the tight binding of pyrazolo[3,4-d]pyrimidines to functional enzyme in the reduced state 
(Edmondson et  a/., 1972). 
The orientation of the nitrogen atoms within substrate analogs is apparently critical 
for the expression of this type of xanthine oxidase inhibition: While a series of pyrazolo- 
[3,4-d]pyrimidines all exhibited behavior like that of allopurinoi in inhibiting the enzyme 
(Figs 2 and 3), a group of pyrazolo[4,3-d]pyrimidines, triazolopyrimidines and pyrroio- 
pyrimidines did not (Massey et  al., 1970b). These latter compounds were found to be 
substrates for the enzyme but in no case were spectral perturbations similar to those of 
the pyrazolo[3,4-d]pyrimidines observed, nor was enzyme inhibition detected. 
A key question remaining as regards the mechanism of inhibition of xanthine oxidase 
by allopurinol and other pyrazolo[3,4-d]pyrimidines has to do with the large number of 
turnovers (thirty or more) required to effect inhibition during aerobic turnover (Massey 
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FIG. 2. Difference spectra (expressed as A~ based on concentration of enzyme-bound flavin) 
between air-reoxidized enzymeand enzyme reduced as indicated. With xanthine as reductant the 
difference calculated was between oxidized enzyme and the spectrum produced immediately after 
addition of xanthine. The difference spectra obtained with the pyrazolo[3,4-d]pyrimidines was, 
for example, that between curves 3 and 2 of Fig. 1 (from Massey et al., 1970b). 
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FIG. 3. Difference spectra between xanthine oxidase inactivated with various pyrazolo[3,4-d]pyri- 
midines and native enzyme. The spectra represent, for example, the difference between curves 3 
and 1 of Fig. I. 
et  a/., 1970a; Spector and Johns, 1970). Why is the enzyme-product complex of alloxan- 
thine with reduced enzyme which is formed in the first turnover unable to prevent 
subsequent turnovers? Clearly the dissociation constant for the first several alloxanthine 
molecules formed must be much greater than that for alloxanthine participating in the 
ultimate inhibitory complex. A clue lies in the observation that, along with a pair of 
electrons, a proton is transferred from substrate to molybdenum in the early steps of 
catalysis (Edmondson et al., 1973). Thus the initial complex on formation of product 
would be alloxanthine. Mo w. H +. The likely sequence of events in the decay of this 
species is alloxanthine dissociation followed by redistribution of electrons from molybde- 
num to iron-sulfur and flavin sites, and proton dissociation. Subsequent rebinding of 
alloxanthine to the molybdenum site of fully reduced enzyme would give rise after a 
number of turnovers to a complex not containing a proton, and conceivably having a 
much lower Ka for alloxanthine. This scheme, while highly speculative, provides a 
mechanistically reasonable explanation for the observed delay in the onset of inhibition 
by allopurinol. 
2.1.2. Clinical Considerations 
Allopurinol has been found to be a clinically effective, well-tolerated drug in the 
treatment of hyperuricemia associated with gout (Elion et al., 1963; Rundles et al., 1969; 
Yu and Cutman, 1964). Doses as high as 700-1000 mg per day can be administered for 
extended periods in relative safety to maintain serum and urinary urate levels well below 
the limit of solubility of 7 mg% (Rundles et al., 1963; Goldfinger, 1971). Significantly, 
allopurinol does not appear to induce synthesis of xanthine oxidase or to shorten its in 
vivo half-life, nor does it increase the steady state levels of the various purine pools 
(Rundles et al., 1969; Goldfinger, 1971). Side-effects are rare, but include leukopenia, 
thrombocytopenia, renal impairment, dermatitis, rashes and mild gastrointestinal dis- 
orders (Rundles et al., 1969; Chalmers et al., 1969). In general, it appears that withdrawal 
of treatment results in amelioration of symptoms when they occur. 
It has been established however, that allopurinol can condense with phosphoribosyl- 
pyrophosphate in a reaction catalyzed by IMP-pyrophosphate phosphoribosyltransferase 
to form a nucleotide with anti-metabolic potential (McCollister et al., 1964; Chalmers et 
al., 1969). Conversion to the nucleoside by purine nucleoside phosphorylase has also 
been reported (Krenitsky et al., 1967). Because the effects of these compounds are un- 
known and could well be deleterious after long periods of time, efforts to find new drugs 
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equally potent as inhibitors of xanthine oxidase but lacking reactivity in these undesir- 
able side reactions have beeen made, 
2.2. OTHER SUBSTRATE ANALOG INHIBITORS OF XANTH1NE OXIDASE 
Historically, the first potent inhibitor of xanthine oxidase discovered was a breakdown 
product of folic acid (Kalckar and Klenow, 1948a,b), later identified as 2-amino-4-hyd- 
roxy-6-formylpteridine, commonly known as 6-pteridylaldehyde (Kalckar et  al., 1948). 
Lowry et al. (1948) determined the K+ for this compound to be 6 x 10- 10 M and showed 
that it was slowly converted by the enzyme to 6-pteridyl carboxylic acid. 
OH OH 
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In at least one instance (aster, 1976)folic acid has been mistakenly used clinically to 
treat hyperuricemia, the effective agent presumably being 6-pteridylaldehyde produced 
from catabolism of folic acid (or present as an impurity in the folic acid to begin with). 
Recent studies by Kaplan (1980) indicate that folic acid itself is probably not an effective 
inhibitor of xanthine oxidase. 
The reaction of 6-pteridylaldehyde with xanthine oxidase may be followed kineticaily 
by observing the increase in long-wavelength absorbance (2m,x = 620 nm) on binding of 
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FIG. 4. The effect of 6-pteridylaldehyde on the spectrum of xanthine oxidase. Solid line; native 
enzyme, in 0.1 M pyrophosphate pH 8.5, 2YC. Dashed line; after the addition of 6-pteridylalde- 
hyde, aerobically. Inset; the relationship between the extinction change observed at 620nm on 
addition of 6-pteridylaldehyde to the fraction of active enzyme in solution. AFR represents the 
activity-to-flavin ratio, a measure of functional enzyme activity with 212 corresponding to fully 
active enzyme. It is defined as the change in absorbance per min at 295 nm in a 3 mi reaction 
volume divided by the absorbance at 450 nm of the xanthine oxidase used in the assay, under the 
standard conditions of 100pM xanthine, 250pM 02, in 0.1 M pyrophosphate, pH 8.5, 25°C. 
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indicate that the species giving the long wavelength absorption arises from a pre-equili- 
brium having a K d of 5 × 10-SM and appears at a limiting rate of 20s -1 at high 
pteridylaidehyde concentrations (Fig. 5) 
E + PTA,  " E '  PTA,  " E. PTA* 
where E - PTA* represents the absorbing species. A rate on the order of 2 × 10- 3 s- 1 FOF 
the reverse reaction of the second step would account for the observed overall Ki of 
10-9 M. The amount of absorbance change observed on addition of pteridylaldehyde to 
enzyme is directly proportional to the specific activity of the enzyme. Prior treatment 
with cyanide, known to chemically alter the active site by removing an essential sulfur 
atom as SCN- (cf. Section 3.1.), is found to prevent the appearance of the long 
wavelength absorption. This in conjunction with the observation that the same absorb- 
ance change was observed on binding of 6-pteridylaldehyde to deflavo enzyme (elimin- 
ating the possibility of flavin radical as the absorbing species) suggests involvement.of the 
molybdenum site (or the cyanolysable sulfur) in the structure of the chromophore. Bind- 
ing of 6-ptendylaldehyde to xanthine oxidase is so tight that substoichiometric 
amounts of inhibitor were found to inhibit the enzyme completely, thus providing the 
first evidence for the existence of nonfunctional forms of xanthine oxidase (Lowry et al., 
1948). It is possible that the long-wavelength absorbing species represents a transient 
covalent intermediate in the catalytic cycle (cf. Fig. 6, intermediate II), dramatically 
stabilized in the case of 6-pteridylaldehyde (Davis, 1980). 
Pursuing another line, Baker and Wood (1967) showed that 9-phenylguanine inhibited 
xanthine oxidase some 140 times more effectively than did 9-methylguanine and that the 
aromatic interaction with enzyme was hydrophobic rather than charge-transfer in nature. 
Further investigation into this hydrophobic interaction led to the tailoring of active-site 
directed irreversible inhibitors of xanthine oxidase (Baker and Wood, 1968a,b; Baker et 
al., 1968). These compounds contained good leaving groups on the aromatic substituents, 
rendering them susceptible to nucleophilic attack by basic amino acid residues near the 
active site of the enzyme and leading to covalent modification of the protein. Among the 
most effective of these inhibitors was the following compound 
O 
[~ N - - C  S - - F  II  II o 
o 
This compound was found to exhibit an 150 of 10- 7 M (under the assay conditions of 
8 F~M xanthine and 250 pM oxygen) and greater than 80~o covalent inhibition after 20 min 
of incubation. The mode of covalent attachment to the enzyme was not determined in 
these studies, but on the basis of the current understanding of the enzyme mechanism 
(Fig. 6), it is tempting to speculate that the nucleophile at the enzyme active site is a 
persulfide residue (cf. Section 3.1.) important in the catalytic cycle. The clinical usefulness 
of these compounds is uncertain due to likely interactions of these compounds with other 
enzymes involved in purine metabolism (Baker and Wood, 1968a,b) and possible nega- 
tive effects on the in t'ivo stability of xanthine oxidase as a result of covalent modification. 
Recently a comprehensive survey of potential inhibitors of xanthine oxidase among 
substituted imidazoles and triazoles was undertaken by Baldwin et al. (1975, 1977). 
Typical of the compounds found most effective in in t'itro enzyme assays were 3-(3-pyridyl)- 
5-(4-pyr idy l ) - l ,2 ,4- t r iazo le  (I) and 2-(4-pyridyl)-4,5-dicyanoimidazole (II). Both of 
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these compounds were some 100-fold more effective than allopurinol, with I5o values at 
300//M hypoxanthine and 250 pM oxygen of 2 x 10- 8 M, compared with I50 for aliopuri- 
nol of 3 x 10 -6 M. Among the triazoles tested it was found that 4-pyrimidinyl, 4-pyridyl, 
5-quinolyl or several halogenated benzene derivatives could be substituted for the 3-pyri- 
dyl residue at position 3 without significant loss of inhibitory capacity, but substitution 
of 2-pyridyl or 2-pyrimidinyl resulted in a thousand-fold decrease in I5o (Baldwin eta/ . ,  
1975). As was the case with the pyrazolo[3,4-d]pyrimidines, the relative positions of the 
nitrogen atoms within the heterocycles are apparently critical for the expression of inhibi- 
tory activity. In the imidazole series, nitro or carboxyl groups were acceptable substitutes 
for the cyano group at positions 4 and 5 (resulting in only a slight loss of inhibition) but 
amido or carboxymethyl groups were not. For both imidazoles and triazoles, a pyridyl 
function and a free imino group in the five-membered ring were required for inhibitory 
activity. These compounds were apparently not hydroxylated by xanthine oxidase (Dug- 
ganet  a/., 1975). 
Springer et al. (1976) reported the inhibition of xanthine oxidase by 5,7-dihydroxypyra- 
zolo[1,5-~]pyrimidines having aromatic substituents at position 3 
OH 
N - - N  
R 
The most potent of these inhibitors, with R = benzyl, 3-pyridyl or 1-naphthyl, exhibited 
Kis 50-fold less than allopurinol (2 x 10-aM, versus 10-6M for allopurinol). These 
workers compared this with a Ki for allopurinol of 10 - 6  M, but 10- 1o M appears to be a 
better estimation of that value (Spector and Johns, 1970). Inhibition was found to be of 
0.15 
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FIG. 5. The dependence of the rate of formation of the long wavelength absorbance from Fig. 4 
on 6-ptcridy]aldehydc concentration. From the intercept and slope of the double reciprocal plot 
values of 20 s-~ for k2 and 5 × 10-SM for k_ ~/k 2 can be determined, respectively, 
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the non-competitive variety, although as Cha points out (Cha, 1975) apparently non- 
competitive inhibition is to be expected regardless of the nature of the enzyme-inhibitor 
interaction, given the very tight binding of these inhibitors. 
In conducting studies of this general nature, two considerations must be kept in mind. 
First, 15o values reflect only an apparent Ki at the given substrate concentrations used in 
the assay. In the absence of additional information it is impossible to extrapolate such 
data to obtain values for the true K~, the parameter that accurately reflects the affinity of 
the inhibitor for the enzyme to which it binds. Cha has discussed this and other problems 
associated with the study of tight-binding inhibitors in general (Cha, 1975) and the 
interaction of allopurinol and alloxanthine with xanthine oxidase in particular (Cha et  
al., 1975). In brief, the relationship o f / s o  to Ki is shown to depend on the type of 
inhibition and may be further complicated by failure to achieve a steady-state condition 
in the course of enzyme assays. The second consideration is that all comparisons of 
prospective drugs seem to be made with allopurinol. In fact, alioxanthine (the product of 
enzyme oxidation of aUopurinol) is the actual inhibitor, and its dissociation constant 
with reduced enzyme is about 10- lo M (Massey et  al., 1970a; Spector and Johns, 1970), 
considerably less than the Iso value of 1 0 - 6 M  for allopurinol used for comparative 
purposes. Such being the case, the apparent attractiveness of many inhibitors becomes 
greatly diminished when compared to alloxanthine. 
3. OTHER INHIBITORS OF XANTHINE OXIDASE 
3.1. CYANIDE 
Cyanide was first shown to inhibit xanthine oxidase by Szent-Gyorgyi (1926). Frido- 
rich and Handler (1958) reported that 14CN- bound to the enzyme with a stoichiometry 
of one molar equivalent per active site, but it was subsequently shown by Massey and 
Edmondson (1970) that this was not the source of inactivation. Rather, cyanide reacted 
with the enzyme to release an essential sulfur atom as thiocyanate. Activity could be 
recovered to a significant extent by incubation with Na2S. When Na235S was used, a 
second treatment with CN-  produced 35SCN-. Using an affinity column procedure 
based on the tight binding of pyrazolopyrimidines to reduced enzyme, Edmondson et  al. 
(1973) were able to separate active and inactive xanthine oxidase, and show that the 
inactive enzyme found in standard preparations was identical to the cyanide-treated, or 
desulfo, species. 
On the basis of the chemical evidence, Massey and coworkers (Massey and Edmond- 
son, 1970; Olson et  al., 1974) have propsed that xanthine oxidase contains a persulfide 
group at its active site. This persulfide is postulated to act as a nucleophile in the course 
of catalysis, as shown in Fig. 6, and be susceptible to cyanolysis in a reaction typical of 
persulfides 
R-SS- + CN-  ~ RS- + SCN- 
In order to explain the observation that treatment with cyanide under anaerobic con- 
ditions results in enzyme reduction, a nearby thiol is proposed that spontaneously 
forms a disulfide with the product of cyanolysis (Massey and Edmondson, 1970). This 
second thiol would also play a part in the binding of arsenite, another inhibitor of 
xanthine oxidase (see below). It is known, however, that fully reduced enzyme is not 
inactivated by cyanide (Fridovich and Handler, 1958), presumably due to a compulsory 
transfer of electrons to Mo in the course of inactivation. Disulfide formation would 
therefore have to be an obligatory step in cyanide inactivation according to the persulfide 
scheme. There appears to be no compelling reason why this must be so. In addition, the 
essential sulfur site exhibits certain properties difficult to recancile with persulfides. For 
example, it is stable at low pH, as evidenced by the fact that native and desulfo enzyme 
release the same amount of acid-labile sulfur (Massey and Edmondson, 1970), and is 
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unreactive with nucleophiles such as hypotaurine, to which the active site should be 
accessible. 
Two alternate proposals regarding the chemical nature of the essential sulfur site have 
been put forward recently. Coughlan (1977) has proposed a cysteinyl residue in complex 
with molybdenum, which is susceptible to nucleophilic attack by CN (Fig. 7A). The 
scheme accounts for the observed stoichiometry of one thiocyanate produced per active 
site, the generation of reducing equivalents in the course of inactivation, and at first 
glance, the known fixation of CN- to the enzyme (Fridovich and Handler, 1958; Cough- 
lan et (11., 1969). However, the scheme predicts one CN- fixed for each SCN- produced. 
This is not in agreement with results of Massey and Edmondson (1970) which showed 
that after one hour in the presence of 9 mM Kt4CN, the enzyme was fully inactivated 
and the stoichiometry of S'4CN - released per active site was 0.96: 1.0, but the amount 
14CN fixed to protein was only 0.39:1.0, In addition, to explain the observation of 
naturally occurring inactive enzyme, and its activation by NazS, the highly speculative 
scheme in Fig. 7B must be proposed. Apart from the uncertain chemistry, it is not clear 
that the dehydroalanine and cyanoalanine species proposed for naturally occurring and 
cyanide inactivated enzyme forms, respectively, would be expected to give the same 
absorption spectra, as is observed (Edmondson et  al., 1972). Also, as was the case with 
the persulfide model, there is no clear reason from this scheme why prior reduction of the 
molybdenum should prevent inactivation. 
A third proposal has been considered by Bray and coworkers (Gutteridge et  al., 1978; 
Bray et  al., 1979). In this model the essential sulfur atom exists as a terminal sulfo ligand 
to the molybdenum. Reaction of this species with CN- would follow the scheme shown 
in Fig. 8 and account for the SCN- and redox equivalent stoichiometry that is observed 
experimentally. Prior reduction of the molybdenum site would probably give rise to a 
species with the following structure, due to the large shifts of pK of Mo ligands generally 




This species would not be expected to be susceptible to CN- because, on the basis of the 
model, Mo would have to be reduced beyond the IV valence state in the course of 
inactivation. Electron paramagnetic resonance data provide further evidence, albeit 
somewhat indirect, in favor of this model. Both native and desulfo xanthine oxidase 
exhibit Mo v signals strongly coupled to protons, but on dilution into DzO the proton of 
the desulfo enzyme exchanges some 200-fold more slowly than the proton of the native 
enzyme. Assuming proton association is diffusion-controlled for both forms of the 
A. 
OCN { I 
O=C / O;C O=C 
H i -  CI42-'~-Mo~--H!-CH2 - CN S~-M0~-~----HC-CH2-CN O=Mo ~2Z 
NH NH ~O HS ~O /H 
HO CN { 
SCNO.H®.2e - 
O=C O=C O=C 
B. H - +  ~J~ ' S( M 0~-~-~ C=CH 2 0 = M o  ~j~" CH2,~_ M o -'~---C= CHo I 
NH ~IO~IH ~ H~ e HS e NH 
FIG. 7. A model for the active site of xanthine oxidase based on cysteine as the source of 
cyanolysable sulfur. A: scheme proposed for the cyanolysis reaction. B: scheme proposed to 
account for naturally occurring inactive enzyme [from Coughlan. 19771, 
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FK;. 8. Scheme for the cyanolysis of a Mo = S complex. 
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enzyme, the above difference in rates of dissociation corresponds to a difference in pK of 
2, with native enzyme being more acidic. This is of the order expected if the protons were 
binding directly to sulfo and oxo ligands in native and desulfo enzyme, respectively, given 
the greater acidity of sulfur-bound protons compared to oxygen-bound ones (Gutteridge 
et al., 1978; Steifel, 1977). Similarly, the much lower redox potential of the molybdenum 
site of desuifo xanthine oxidase compared to that of native enzyme ( - 4 6 0 m V  vs 
-355  mV, respectively; Cammack et al., 1976) may be held as consistent with the substi- 
tution of oxygen for sulfur in the desulfo species. Recent data from extended X-ray 
absorption fine structure (EXAFS) experiments support the notion that the sulfur lies in 
the coordination sphere of molybdenum (Bordas et al., 1980). In this method, the attenu- 
ation of X-ray absorption due to the presence of nuclei in the vicinity of the absorbing 
nucleus (in this case molybdenum) is simulated empirically using parameters obtained 
from studies on model compounds of known three dimensional structure. EXAFS has 
proven extremely sensitive to the type of atom and its distance from the absorbing 
nucleus, and a comparison of the EXAFS spectra for native and desulfo xanthine oxidase 
clearly indicates a difference in the molybdenum environment of the two enzyme forms. 
Unfortunately, while this difference reflected changes in xanthine oxidase coordination at 
a distance consistent with those expected for the conversion of Mo=S to Mo---O, simula- 
tions were not able to demonstrate unambiguously the loss of a sulfur atom and the gain 
of an oxygen atom in the coordination sphere of xanthine oxidase on treatment with 
cyanide. In a comparative study of the EXAFS spectra of sulfite oxidase and xanthine 
oxidase with a series of model compounds (Berg et al., 1979; Tullius e ta / . ,  1979) it was 
found that sulfite oxidase yielded a spectrum virtually identical to that of the compound 
shown in Fig. 9. Xanthine oxidase gave a somewhat different, although still very similar 
EXAFS spectrum. The xanthine oxidase sample used in these studies, however, was not 
fully active and therefore heterogeneous as regards the molybdenum center. The EXAFS 
spectrum of the desulfo form (Bordas e ta / . ,  1980) appears to resemble more closely that 
of the model compound (Tullius et al., 1979) although direct comparison of spectra from 
the two references is difficult. 
The observation most difficult to explain with the Mo--S model comes from experi- 
ments using a Neurospora mutant that synthesizes aponitrate reductase but not appar- 
ently, an essential molybdenum cofactor {Ketchum et a/., 1970; Nason et al., 1971). 
Rajagopalan and coworkers have reported that the molybdenum cofactor isolated by 
acid treatment from cyanide-treated as well as native xanthine oxidase is capable of 
restoring nitrate reductase activity to the Neurospora apoenzyme (Hainline e ta / . ,  1979L 
This result is inconsistent with the notion that the essential sulfur is an integral part of a 
molybdenum cofactor as it must be if it exists as Mo=S. It may be possible, however, to 
"x,~1 s 
CH3 
FIG. 9. The structure of MoO2[(SCH2CH2)2NCH2CH2SCH~],  a model for the active site of 
xanthine oxidase. 
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reconcile these results with the Mo--S model. Neither sulfite oxidase (which can also 
provide molybdenum cofactor active in the Neurospora reconstitution experiment) nor 
nitrate reductase appear to be inhibited by cyanide in the same way as xanthine oxidase; 
i.e. by releasing sulfur in the form of thiocyanate. It is conceivable that Mo=O, formed 
spontaneously from Mo=S in the acid extraction step in the case of native xanthine 
oxidase and occurring naturally in the case of sulfite oxidase, is the species responsible 
for the reconstitution of nitrate ieductase activity and that the sulfur needed for xanthine 
oxidase activity is not required. While this would offeran explanation for the striking 
similarity in the ESAFS spectra of sulfite oxidase and desulfo xanthine oxidase to the 
model compound of Fig. 9, and the slight difference in the case of native xanthine 
oxidase, more work is clearly needed. It is difficult to explain, for example, the well- 
established inhibition of cyanaolysis by arsenite (Rajagopalan and Handler, 1964; Mas- 
sey and Edmondson, 1970) in terms of the Mo--S model. The only known mechanism of 
action of arsenite is to complex very tightly to dithiols, and the extent to which Mo=S 
would exhibit thiol-character is unclear. While a prototropic equilibrium such as dis- 
cussed above might be invoked to generate MoW-SH, this species, if formed, does not 
react with Kenyon's reagent [methylmethanethiosulfonate (Smith et  al., 1975)] in the pH 
range 7-10 to result in loss of activity (R. Hille, unpublished data), nor with DTNB 
(Massey et  al., 1970a) and so cannot be considered to have the general properties of a 
thiol. 
3.2. METHANOL AND FORMALDEHYDE 
Methanol inhibits xanthine oxidase when incubated in the presence of xanthine (Raja- 
gopalan and Handler, 1967; Coughlan et  al., 1969) and gives rise to a characteristic EPR 
signal attributable to Mo v (Aleman-Aleman et  al., 1965). This signal, termed 'Inhibited' 
by Bray and Vanngard (1969), exhibits a doublet structure indicating that molybdenum is 
coupled tO a single proton. The Inhibited signal generated by using C2H3OH does not 
show this doublet structure even when incubated in H20  for prolonged periods, indicat- 
ing that the proton coupled to molybdenum in the signal-giving species is derived from 
the methanol itself and is not exchangeable with the bulk solvent (Pick et  al., 1971). 
Dialysis at high temperatures or extremes in pH, or incubation with Na2S20+ or 
KaFe(CN)6 causes the Inhibited molybdenum V signal to disappear and at least partially 
restores activity. Unlike the other EPR signals of xanthine oxidase, the Inhibited signal is 
air stable. 
Formaldehyde also produces the Inhibited signal with xanthine oxidase, and is able to 
do so in the absence of added xanthine (Pick et  al., 1971). It is likely that methanol is 
converted to formaldehyde prior to its inactivation of the enzyme. Like methanol, for- 
maldehyde is capable of reducing xanthine oxidase (Booth, 1938; Bray and Meriweather, 
1966; Pick and Bray, 1969). Attack by persulfide (or any good nucleophile) on the 
carbonyi carbon of formaldehyde, in a reaction analogous to the first step of Fig. 6, 
might give rise to a structure with features consistent with the data (Fig. 10). This 
involvement of the persulfide would be in agreement with the observation that NC -  and 
formaldehyde are mutually exclusive in their actions on the enzyme (Edmondson e t  al., 
1972). Whatever the structure of the inactivated enzyme, it must provide sufficient stabil- 
ization of Mo v to account for the air-stability of the Inhibited EPR signal. This could be 
I 
 A0 tFA0 tFA° tFAo 
F,/s pF, s x t F,,/s. 
Mo ~ H • L Mo~--~. H ~ h~ IV  H -~Mo~ ~ 
c + o  _ 
FIG. 10. Scheme proposed for the reaction of xanthine oxidase with formaldehyde giving rise to 
the enzyme species characterized by the Inhibited Mo v EPR signal. 
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accomplished by raising the redox potential of MoVI-Mo v couple and/or lowering that of 
the flavin, where reaction with oxygen takes place. 
Ethylene glycol (Tanner and Bray, 1978a,b) and mercaptoethanol (R. Hille, unpub- 
lished results) also inhibit xanthine oxidase and are capable of transferring reducing 
equivalents to it. The former has been shown to be converted to glyoxylate and oxalate 
by the enzyme (Tanner and Bray, 1978) and give rise to an EPR signal identical to the 
Inhibited signal except for the absence of doublet structre. This absence of splitting is 
consistent with the observation that the products expected to be involved in inactivation, 
glyoxylate and/or oxalate, contain only one carbonyl proton, which would be lost in the 
course of inactivation. 
3.3. ARSENITE 
Inhibition of xanthine oxidase by arsenite was first reported by Mackler et al. (1954). It 
was also studied briefly by Peters and Sanadi (1961). The importance of the arsenite 
inhibition to our understanding of the mechanism of xanthine oxidase did not become 
clear until Coughlan et  al. (1969) reported that arsenite treatment, like cyanide, resulted 
in a spectral change of the enzyme which was coincident with the development of 
inhibition. They also made the important finding that cyanide and arsenite inhibition are 
mutually exclusive; prior reaction with cyanide prevents the appearance of the spectral 
changes typical of arsenite inhibition, and conversely, prior complexing with arsenite 
severely interferes with cyanide inactivation. The important observation was also made 
that whereas cyanide inactivation appeared to be irreversible (but see earlier section of 
cyanide inactivation), the effect of arsenite was reversible by dilution, e.g. by dialysis. 
They noted also that while the inhibition of xanthine oxidase by arsenite was a slow 
process, the closely related enzyme, liver aldehyde oxidase, was inhibited immediately 
(< l0 sec) by 10-4M arsenite, and that this inhibition was reversed rapidly on dilution. 
Thus they concluded that the effects of arsenite and cyanide were mutually exclusive, and 
that they both interacted with the enzyme bound molybdenum. As described in the 
previous section, this concept was discredited by the discovery of the cyanolysable sulfur 
in this group of enzymes, and the demonstration that this particular sulfur atom was 
essential for normal catalysis (Massey and Edmondson, 1970). The mutually exclusive 
reactions of cyanide and arsenite were, however, confirmed, and it was proposed that the 
common factor was their interaction with the cyanolysable sulfur atom. This was shown 
experimentally by the linear relationship between catalytic activity, cyanolysable sulfur 
and the extinction change at 380 nm due to complex formation with arsenite. The same 
relationship has also been found to exist for the ability to bind rapdily alloxanthine and 
other pyrazoio[3,4-d]pyrimidines, and for rapid reduction of the enzyme by substrate 
(Edmondson et al., 1972). The great importance of the cyanolysable sulfur atom to the 
properties of the enzyme were thus immediately obvious. Of the various hypotheses put 
forward to account for the chemical nature of this sulfur atom, none is entirely satisfac- 
torY. Only that proposed by Massey and Edmondson (1970) deals straightforwardly with 
the inhibition by arsenite in a way with known precedents, i.e. the strong complexing of 
arsenite with vicinal thiols. However, a point which has perhaps not received the atten- 
tion it deserves, is the s lowness  of the reactions of cyanide and arsenite with milk xan- 
thine oxidase ICoughlan, et al., 1969; Massey and Edmondson, 1970). This suggests that 
the form(s) of the enzyme reacting with these reagents may be minor equilibrium species. 
In this respect it is intriguing that aldehyde oxidase reacts rapidly with both cyanide and 
arsenite ICoughlan et al., 1969) and that all preparations so far reported show substantial 
amounts of a Mo v EPR signal in the resting enzyme (Rajagopalan et al., 1968). 
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